Sign In

Afisi Ismaila

Global Value Evidence Leader, COPD Portfolio at GSK

Afisi Ismaila, PhD, is a Senior Director and Therapy Area Head for Renal and Hepatology in Value Evidence and Outcomes at GSK, based in the Greater Philadelphia area.1 He has extensive experience in health research, evidence evaluation, and health economics.

Ismaila's background includes:

  1. A role as a Biostatistician & Health Research Methodologist at McMaster University from May 2004 to December 2007.1
  2. Expertise in conducting systematic reviews and network meta-analyses, particularly in the field of COPD research.2
  3. Involvement in health economic impact studies, such as adapting models for PHiD-CV in Canada and the UK.4

Ismaila has over 500 connections on LinkedIn and is known for sharing content related to young artists and professional accomplishments.3 His work has been published in peer-reviewed journals, demonstrating his contributions to medical research and health economics.24

Highlights

Comparative efficacy of long-acting muscarinic antagonist ...
Oct 25 · tandfonline.com
Health and economic impact of PHiD-CV in Canada and the UK

Related Questions

What are Afisi Ismaila's main responsibilities at GSK?
How did Afisi Ismaila transition from McMaster University to GSK?
What specific studies has Afisi Ismaila contributed to in the COPD field?
What is Afisi Ismaila's educational background?
How has Afisi Ismaila's work impacted the treatment of COPD?
Afisi Ismaila
Afisi Ismaila, photo 1
Afisi Ismaila, photo 2
Add to my network

Location

Greater Philadelphia